Assessment of Immune Status in Patients with Mismatch Repair Deficiency Endometrial Cancer.

Jincheng MaJiansong LinXite LinYuan RenDabin LiuShuting TangLeyi HuangShuxia XuXiaoDan Mao Peng-Ming Sun

Published in: Journal of inflammation research (2024)

Patients with MMRd-EC can be subclassified according to MutS or MutL deficiency. Patients with MutS-d exhibited better immune status, prognosis, and immunotherapy benefits than those with MutL-d. These results can help guide patients to a more precise treatment.

Keyphrases

endometrial cancer
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
replacement therapy
combination therapy